Peking University International Hospital is a non-profit hospital affiliated with Peking University.

There are 1,800 beds in Peking University International Hospital.

During the past decade, Peking University International Hospital conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 2 clinical trials were completed, i.e. on average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 2 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peking University International Hospital" #1 sponsor was "Peking University First Hospital" with 3 trials, followed by "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 2 trials sponsored, "Peking University" with 2 trials sponsored, "Peking University International Hospital" with 2 trials sponsored and "Shanghai Henlius Biotech" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peking University International Hospital" #1 collaborator was "Peking University International Hospital" with 12 trials as a collaborator, "Qingdao Municipal Hospital" with 3 trials as a collaborator, "Beijing 302 Hospital" with 2 trials as a collaborator, "Beijing Friendship Hospital" with 2 trials as a collaborator and "Beijing Hospital" with 2 trials as a collaborator. Other collaborators include 96 different institutions and companies that were collaborators in the rest 99 trials.

According to Clinical.Site data, the most researched conditions in "Peking University International Hospital" are "Moyamoya Disease" (3 trials), "Brain Metastases" (2 trials), "Gastric Cancer" (2 trials), "HER2-positive Breast Cancer" (2 trials) and "Non Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Peking University International Hospital" in a lesser frequency.

Most popular intervention types in "Peking University International Hospital" are "Drug" (26 trials), "Procedure" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Almonertinib" (2 trials), "Almonertinib plus carboplatin and pemetrexed" (2 trials), "Apatinib" (2 trials), "Cyclophosphamide" (2 trials) and "HLX10" (2 trials). Other intervention names were less common.

The vast majority of trials in "Peking University International Hospital" are 28 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Peking University International Hospital". 5 are not yet recruiting, 11 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Peking University International Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peking University International Hospital, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".

Peking University International Hospital has several departments that took part in Clinical trials: "Department of Nutrition and Food Hygiene" - 5 trials